Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Mine Safety
MSA
$7.41B
| $2.67M | ﹤0.01% |
18,225
-12,967
| -42% | -$2.07M |
|
2377
Greif
GEF
$5B
| $2.67M | ﹤0.01% |
48,576
-20,038
| -29% | -$1.18M |
|
2378
National Bank Holdings
NBHC
$1.92B
| $2.67M | ﹤0.01% |
69,761
-22,218
| -24% | -$925K |
|
2379
MYR Group
MYRG
$5.18B
| $2.67M | ﹤0.01% |
23,605
-7,706
| -25% | -$1.02M |
|
2380
Kearny Financial
KRNY
$600M
| $2.67M | ﹤0.01% |
426,314
-31,807
| -7% | -$218K |
|
|
OPLN
2381
Openlane
OPLN
$4.34B
| $2.67M | ﹤0.01% |
138,302
-50,815
| -27% | -$1.05M |
|
2382
PUT
Match Group
MTCH
$8.4B
| $2.66M | ﹤0.01% |
+85,400
| New | +$2.79M |
|
|
DX
2383
Dynex Capital
DX
$3.23B
| $2.66M | ﹤0.01% |
204,598
-59,841
| -23% | -$802K |
|
2384
Stewart Information Services
STC
$2B
| $2.66M | ﹤0.01% |
37,277
-10,460
| -22% | -$708K |
|
|
WSR
2385
DELISTED
Whitestone REIT
WSR
| $2.66M | ﹤0.01% |
182,259
+16,433
| +10% | +$226K |
|
2386
Minerals Technologies
MTX
$2.25B
| $2.65M | ﹤0.01% |
41,748
-44,989
| -52% | -$3.21M |
|
2387
Steven Madden
SHOO
$3.49B
| $2.64M | ﹤0.01% |
99,278
-40,486
| -29% | -$1.42M |
|
|
EVRI
2388
DELISTED
Everi Holdings
EVRI
| $2.64M | ﹤0.01% |
192,844
-60,445
| -24% | -$825K |
|
|
SNDK
2389
Sandisk
SNDK
$223B
| $2.64M | ﹤0.01% |
+55,369
| New | +$2.75M |
|
2390
PUT
Dycom Industries
DY
$12.3B
| $2.64M | ﹤0.01% |
+17,300
| New | +$2.98M |
|
2391
CALL
iShares Biotechnology ETF
IBB
$9.77B
| $2.63M | ﹤0.01% |
20,600
| – | – |
|
|
2392
PUT
iShares Biotechnology ETF
IBB
$9.77B
| $2.63M | ﹤0.01% |
20,600
-13,400
| -39% | -$1.82M |
|
2393
Neogen
NEOG
$2.5B
| $2.63M | ﹤0.01% |
302,811
-172,554
| -36% | -$1.81M |
|
|
AVDL
2394
DELISTED
Avadel Pharmaceuticals
AVDL
| $2.62M | ﹤0.01% |
334,925
+164,505
| +97% | +$1.38M |
|
2395
CALL
UnitedHealth
UNH
$364B
| $2.62M | ﹤0.01% |
5,000
-2,200
| -31% | -$1.12M |
|
2396
Kodiak Gas Services
KGS
$6.26B
| $2.61M | ﹤0.01% |
70,100
+12,600
| +22% | +$537K |
|
2397
Ligand Pharmaceuticals
LGND
$5.85B
| $2.61M | ﹤0.01% |
24,850
-15,122
| -38% | -$1.71M |
|
2398
PUT
Coca-Cola Europacific Partners
CCEP
$47.3B
| $2.61M | ﹤0.01% |
+30,000
| New | +$2.45M |
|
2399
Invesco Mortgage Capital
IVR
$802M
| $2.61M | ﹤0.01% |
330,616
+118,183
| +56% | +$996K |
|
2400
Monro
MNRO
$359M
| $2.61M | ﹤0.01% |
180,260
+75,512
| +72% | +$1.44M |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.